trastuzumab
Not Tagged
['bcsm', 'trastuzumab,(-trastuzumab deruxtecan),(-trastuzumab-deruxtecan)']
super important results of the short-her study of 9 weeks vs. 1 year of #trastuzumab in #her2 #bcsm. only a 1% absolute difference in 10y survival! most of the benefit of longer therapy were seen in stage 3. with this &amp; persephone, shouldn't we start to shorten treatment? #asco23 
Geriatric Oncologist @incmnszmx #gerionc, Global Oncology. @ASCO BOD 20-24, FASCO. PhD @UNAM_MX Opinions my own. 🇲🇽 https://t.co/GruVowjxCI…